11C-methionine positron emission tomographic imaging of biologic activity of a recurrent glioblastoma treated with stereotaxy-guided laser-induced interstitial Thermotherapy

Molecular Imaging

Volumn 11, Issue 4, 2012, Pages 265-271

  Galldiks, Norbert ^a,b,c   Von Tempelhoff, Wernholt ^a,b,c   Kahraman, Deniz ^a,b,c   Kracht, Lutz W ^a,b,c   Vollmar, Stefan ^a,b,c   Fink, Gereon R ^a,b,c   Schroeter, Michael ^a,b,c   Goldbrunner, Roland ^a,b,c   Schmidt, Matthias ^a,b,c   Maarouf, Mohammad ^a,b,c  

^a UNIVERSITY OF COLOGNE   (Germany)

^b MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

^c FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGIC ACTIVITIES; CLINICAL VALUE; COMPUTED TOMOGRAPHY; CONTRAST-ENHANCED; GLIOBLASTOMA MULTIFORME; GLIOBLASTOMAS; LASER INDUCED INTERSTITIAL THERMOTHERAPY; METABOLIC EFFECTS; MINIMALLY INVASIVE TREATMENTS; MINIMALLY-INVASIVE TECHNIQUE; MULTI-STEP; OPEN SURGERY; POSITRON EMISSION; SIDE EFFECT; THERAPEUTIC EFFECTS; TOMOGRAPHIC IMAGING; TUMOR VOLUMES; VOLUME OF INTEREST ANALYSIS;

AMINO ACIDS; COAGULATION; COMPUTERIZED TOMOGRAPHY; LASER TISSUE INTERACTION; PHYSICAL THERAPY; POSITRON EMISSION TOMOGRAPHY; TUMORS;

PATIENT TREATMENT;

CARBON; METHIONINE;

CASE REPORT; DIAGNOSTIC USE; FATALITY; GLIOBLASTOMA; HUMAN; HYPERTHERMIC THERAPY; LASER; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING; STEREOTACTIC PROCEDURE;

CARBON RADIOISOTOPES; FATAL OUTCOME; GLIOBLASTOMA; HUMANS; HYPERTHERMIA, INDUCED; LASERS; METHIONINE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; STEREOTAXIC TECHNIQUES;

EID: 84866844796     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2011.00046     Document Type: Article

References (28)

1. Brem H, Piantadosi S, Burger PC, et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group. Lancet 1995;345: 1008-12, doi:10.1016/S0140-6736(95)90755-6.
2. Barker FG 2nd, Chang SM, Gutin PH, et al. Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery 1998;42:709-20, doi:10.1097/00006123-199804000-00013.
3. Leonardi MA, Lumenta CB. Stereotactic guided laser-induced interstitial thermotherapy (SLITT) in gliomas with intraoperative morphologic monitoring in an open MR: clinical expierence. Minim Invasive Neurosurg 2002;45:201-7, doi:10.1055/s-2002-36203.
4. Kahn T, Bettag M, Ulrich F, et al. MRI-guided laser-induced interstitial thermotherapy of cerebral neoplasms. J Comput Assist Tomogr 1994;18:519-32, doi:10.1097/00004728-199407000-00002.
5. Schwarzmaier HJ, Eickmeyer F, von Tempelhoff W, et al. MRguided laser irradiation of recurrent glioblastomas. J Magn Reson Imaging 2005;22:799-803, doi:10.1002/jmri.20446.
6. Schwarzmaier HJ, Eickmeyer F, von Tempelhoff W, et al. MRguided laser-induced interstitial thermotherapy of recurrent glioblastoma multiforme: preliminary results in 16 patients. Eur J Radiol 2006;59:208-15, doi:10.1016/j.ejrad.2006.05.010.
7. Galldiks N, Kracht LW, Burghaus L, et al. Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas. Eur J Nucl Med Mol Imaging 2006;33:516-24, doi:10.1007/s00259-005-0002-5.
8. Ribom D, Eriksson A, Hartman M, et al. Positron emission tomography (11)C-methionine and survival in patients with lowgrade gliomas. Cancer 2001;92:1541-9, doi:10.1002/1097-0142 (20010915)92:6,1541::AID-CNCR1480.3.0. CO;2-D.
9. Pöpperl G, Götz C, Rachinger W, et al. Serial O-(2-[(18)F]fluoroethyl)-L-tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant glioma. Eur J Nucl Med Mol Imaging 2006;33:792-800, doi:10.1007/s00259-005-0053-7.
10. Pöpperl G, Goldbrunner R, Gildehaus FJ, et al. O-(2-[18F] fluoroethyl)-L-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma. Eur J Nucl Med Mol Imaging 2005;32: 1018-25, doi:10.1007/s00259-005-1819-7.
11. Piroth MD, Pinkawa M, Holy R, et al. Prognostic value of early [(18)f]fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme. Int J Radiat Oncol Biol Phys 2011;80:176-84, doi:10.1016/j.ijrobp.2010.01.055.
12. Bettag M, Ulrich F, Schober R, et al. Stereotactic laser therapy in cerebral gliomas. Acta Neurochir (Wien) 1991;52:81-3.
13. Kaschten B, Stevenaert A, Sadzot B, et al. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine. J Nucl Med 1998;39:778-85.
14. Mahasittiwat P, Mizoe JE, Hasegawa A, et al. l-[Methyl-(11)C] methionine positron emission tomography for target delineation in malignant gliomas: impact on results of carbon ion radiotherapy. Int J Radiat Oncol Biol Phys 2008;70:515-22, doi:10.1016/j.ijrobp.2007.06.071.
15. Nuutinen J, Sonninen P, Lehikoinen P, et al. Radiotherapy treatment planning and long-term follow-up with [(11)C] methionine PET in patients with low-grade astrocytoma. Int J Radiat Oncol Biol Phys 2000;48:43-52, doi:10.1016/S0360-3016 (00)00604-0.
16. Voges J, Herholz K, Holzer T, et al. 11C-Methionine and 18F-2-fluorodeoxyglucose positron emission tomography: a tool for diagnosis of cerebral glioma and monitoring after brachytherapy with 125I seeds. Stereotact Funct Neurosurg 1997;69:129-35, doi:10.1159/000099864.
17. Würker M, Herholz K, Voges J, et al. Glucose consumption and methionine uptake in low-grade gliomas after iodine-125 brachytherapy. Eur J Nucl Med 1996;23:583-6, doi:10.1007/BF00833397.
18. Berger G, Maziere M, Knipper R, et al. Automated synthesis of 11C-labelled radiopharmaceuticals: imipramine, chlorpromazine, nicotine and methionine. Int J Appl Radiat Isot 1979;30:393-9, doi:10.1016/0020-708X(79) 90049-8.
19. Galldiks N, Ullrich R, Schroeter M, et al. Volumetry of [(11)C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme. Eur J Nucl Med Mol Imaging 2010;37:84-92, doi:10.1007/s00259-009-1219-5.
20. Vollmar S, Hampl J, Kracht L, Herholz K. Integration of functional data (PET) into brain surgery planning und neuronavigation. Springer Proc Phys 2007;114:98-103, doi:10.1007/978-3-540-68764-1-16.
21. Kinoshita M, Hashimoto N, Goto T, et al. Use of fractional anisotropy for determination of the cut-off value in 11Cmethionine positron emission tomography for glioma. Neuroimage 2009;45:312-8, doi:10.1016/j.neuroimage.2008. 11.034.
22. Kracht LW, Miletic H, Busch S, et al. Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology. Clin Cancer Res 2004;10:7163-70, doi:10.1158/1078-0432.CCR-04-0262.
23. Herholz K, Kracht LW, Heiss WD. Monitoring the effect of chemotherapy in a mixed glioma by C-11-methionine PET. J Neuroimaging 2003;13:269-71.
24. Galldiks N, Kracht LW, Burghaus L, et al. Patient-tailored, imaging-guided, long-term temozolomide chemotherapy in patients with glioblastoma. Mol Imaging 2010;9:40-6.
25. Galldiks N, Ullrich R, Schroeter M, et al. Imaging biological activity of a glioblastoma treated with an individual patienttailored, experimental therapy regimen. J Neurooncol 2009;93: 425-30, doi:10.1007/s11060-008-9790-3.
26. Pöpperl G, Götz C, Rachinger W, et al. Value of O-(2-[18F]fluoroethyl)-L-tyrosine PET for the diagnosis of recurrent glioma. Eur J Nucl Med Mol Imaging 2004;31:1464-70, doi:10.1007/s00259-004-1590-1.
27. Chen W, Geist C, Czernin J, et al. Assess treatment response using FDOPA PET in patients with recurrent malignant gliomas treated with bevacizumab and irinotecan. J Nucl Med Meeting Abstracts 2008;49:78.
28. Pirotte BJ, Levivier M, Goldman S, et al. Positron emission tomography-guided volumetric resection of supratentorial high-grade gliomas: a survival analysis in 66 consecutive patients. Neurosurgery 2009;64:471-81, doi:10.1227/01.NEU.0000338949.94496.85.